In this regard, transducing T cells with a CAR-construct containing the CD137 cytosolic tail together with the CAR-CD3ζ proved to be effective in increasing CTL cell survival, targeting of CTLs to the tumor and boosting anti-tumor activities (119). The gene discussed is TNFRSF9; the disease is neoplasm.